Tokai Pharmaceuticals (TKAI) IPO Surges Higher
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/29/2026
- Wall St set to climb as US, Iran halt attacks; Comcast surges on spin-off plan
- Tech funds suffer record outflows as investors trim equity positions
- Comcast shares surge 23% on blockbuster plan to spin off NBCUniversal and Sky
- New leader board: Citi refreshes AI compute semiconductor picks
- Martin Marietta confirms $13.5B deal for Lhoist North America
- Needham Starts NeoVolta (NEOV) at Buy
- Personalis, Inc. (PSNL) and Tempus (TEM) Expand Collaboration
- Micron ships 245TB data center SSD, claims world's highest capacity
- Triller to acquire SpaceX exposure as treasury asset via fund structure
- Strategy stock jumps 7% as firm shifts to active capital management
Tokai Pharma (TKAI) Looks for More Post-IPO Gains
September 18, 2014 7:23 AM EDTTokai Pharma (Nasdaq: TKAI) is adding to Wednesday's gains.
Ahead of the bell, Tokai Pharma is up over 8 percent. The stock closed 58.4 percent higher yesterday following strong IPO pricing and debut.
For more color on Tokai's IPO, click here.
... More